LINC02688
gene geneOn this page
Summary
LINC02688 (long intergenic non-protein coding RNA 2688, HGNC:54184) is a long non-coding RNA gene on chromosome 11p15.5.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:54184 |
| Approved symbol | LINC02688 |
| Name | long intergenic non-protein coding RNA 2688 |
| Location | 11p15.5 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000254872 |
| Ensembl biotype | lncRNA |
| Entrez | 101927503 |
| RNAcentral | URS0000E60B51 — lncRNA, 1109 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000534584, ENST00000617529, ENST00000737478, ENST00000737479, ENST00000737480, ENST00000737481, ENST00000737482
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000534584 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002154953 | 1054239 | 1054392 |
| ENSE00002199784 | 1051623 | 1051843 |
| ENSE00004071809 | 1049879 | 1049962 |
| ENSE00004071813 | 1040744 | 1040919 |
| ENSE00004071814 | 1055114 | 1055752 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 81.04.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1083 / max 84.7178, expressed in 14 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 112351 | 0.0575 | 12 |
| 112353 | 0.0370 | 5 |
| 112352 | 0.0137 | 4 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| duodenum | UBERON:0002114 | 81.04 | gold quality |
| spleen | UBERON:0002106 | 75.92 | gold quality |
| gall bladder | UBERON:0002110 | 70.76 | gold quality |
| nucleus accumbens | UBERON:0001882 | 70.27 | gold quality |
| bone marrow cell | CL:0002092 | 69.80 | silver quality |
| body of stomach | UBERON:0001161 | 67.31 | gold quality |
| stomach | UBERON:0000945 | 66.94 | gold quality |
| bone marrow | UBERON:0002371 | 66.86 | gold quality |
| endocervix | UBERON:0000458 | 66.78 | gold quality |
| body of pancreas | UBERON:0001150 | 66.53 | gold quality |
| putamen | UBERON:0001874 | 66.50 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 66.08 | gold quality |
| cortex of kidney | UBERON:0001225 | 65.77 | gold quality |
| caudate nucleus | UBERON:0001873 | 65.42 | gold quality |
| transverse colon | UBERON:0001157 | 64.38 | gold quality |
| rectum | UBERON:0001052 | 64.31 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.26 | gold quality |
| pancreas | UBERON:0001264 | 62.83 | gold quality |
| right uterine tube | UBERON:0001302 | 62.56 | gold quality |
| small intestine | UBERON:0002108 | 62.35 | gold quality |
| metanephros cortex | UBERON:0010533 | 62.14 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 61.95 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 61.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.83 | gold quality |
| prostate gland | UBERON:0002367 | 61.45 | gold quality |
| kidney | UBERON:0002113 | 60.80 | gold quality |
| cerebellar cortex | UBERON:0002129 | 60.26 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 60.23 | gold quality |
| cerebellum | UBERON:0002037 | 60.15 | gold quality |
| intestine | UBERON:0000160 | 59.96 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.23 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.